Loading

Peter Crock

CEO - Cann Group, Chair - Medicinal Cannabis Industry Australia

About

Drawing on nearly three decades experience at global agribusiness Nufarm (ASX: NUF), Cann Group’s CEO Peter Crock is helping to shape the future of the medicinal cannabis industry in Australia. With Peter at the helm and working closely with an experienced board of directors, Cann Group (ASX: CAN) received the first commercial cultivation licence in Australia, and was the first medicinal cannabis company to successfully list via an Initial Public Offering (IPO) on the Australian Securities Exchange (ASX), raising AUD$13.5 million in shareholder capital.

To accelerate organisational growth, Cann Group completed an additional AUD$70m capital raise, which has enabled the advancement of its’ most ambitious project to date; a controlled environment, automated production facility which will be able to produce 70,000kg of medicinal cannabis products per year when at full capacity. With deep knowledge and experience in the areas marketing, business and technology development, as well as mergers and acquisitions, Peter has overseen the growth and advancement of Cann Group.

CEO Roundtable
3/4/20 11:45 am
Back to program
Back to Speakers

Cann Group Limited

Established in 2014, Cann Group is the first company to be issued with a Cannabis Research Licence by the Australian Government’s Office of Drug Control (ODC) in February 2017.
Read more
Join Us!

Register your interest to attend and stay up to date with our latest news.

Register